<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>transitions of care &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/transitions-of-care/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Oct 2026 04:08:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>transitions of care &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Why Long-Term Drug Treatment Is Becoming an Organizational Problem, Not Just a Clinical One</title>
		<link>https://bioengineer.org/why-long-term-drug-treatment-is-becoming-an-organizational-problem-not-just-a-clinical-one/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 19 Oct 2026 04:08:41 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Chronic Diseases]]></category>
		<category><![CDATA[continuity of care]]></category>
		<category><![CDATA[Digital Health]]></category>
		<category><![CDATA[health literacy]]></category>
		<category><![CDATA[interprofessional collaboration]]></category>
		<category><![CDATA[medication reconciliation]]></category>
		<category><![CDATA[Multimorbidity]]></category>
		<category><![CDATA[Patient Safety]]></category>
		<category><![CDATA[pharmaceutical care]]></category>
		<category><![CDATA[Pharmacotherapy]]></category>
		<category><![CDATA[polypharmacy]]></category>
		<category><![CDATA[transitions of care]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=436430</guid>

					<description><![CDATA[A new conceptual analysis argues that prolonged multiprofessional pharmacotherapy in chronic diseases has become an organizationally complex process in which fragmented information, partial therapeutic visibility, and the patient's role as the most consistent participant now shape treatment quality as much as clinical decisions do.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">436430</post-id>	</item>
	</channel>
</rss>
